Cipla Backs Chase For Alzheimer’s Drug Research
This article was originally published in The Pink Sheet Daily
Executive Summary
The top-tier Indian generic company is moving fast into unexpected research territories. In the latest announcement, Cipla said it will partly fund Chase’s Alzheimer’s programs and keep looking for more such opportunities.